Jump to content

Portal:Viruses

From Wikipedia, the free encyclopedia
(Redirected from Portal:Virus)

The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

British World War 2 poster, stressing the economic cost of the common cold
British World War 2 poster, stressing the economic cost of the common cold

The common cold is an upper respiratory tract disease that mainly affects the nose, and sometimes the throat, larynx and sinuses. Over 200 viruses can cause colds, most commonly rhinoviruses but also coronaviruses, influenza viruses, adenoviruses and others. Adults catch an average of 2–3 colds a year and children 6–8, making it the most common infectious human disease. The economic costs are huge, with colds responsible for 40% of time lost from work in the U.S. Colds are described in the Egyptian Ebers papyrus, the oldest surviving medical text, written before the 16th century BCE.

Symptoms include cough, sore throat, runny nose, nasal congestion, sneezing and sometimes muscle aches and headache; fever is common in young children. Symptoms typically resolve in 7–10 days, although some can last up to 3 weeks. The immune response to infection, rather than tissue destruction by the virus, causes most of the symptoms. Transmission occurs via airborne droplets and by contact with nasal secretions or contaminated objects. The viruses that cause colds can survive for prolonged periods in the environment (over 18 hours for rhinoviruses). Hand washing can help to prevent spread. No effective antiviral treatment or vaccine currently exists.

Selected image

Ribbon diagram showing T7 RNA polymerase (blue) making messenger RNA (green) based on a DNA template (orange)

Some viruses, such as the T7 bacteriophage, encode their own RNA polymerase, the enzyme that makes messenger RNA based on a DNA template. The T7 enzyme has a single subunit, and is more like chloroplast and mitochondrial enzymes than those of bacteria or the cell.

Credit: Thomas Splettstoesser (25 June 2007)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Martinus Beijerinck in his laboratory in 1921
Martinus Beijerinck in his laboratory in 1921

The history of virology is usually considered to begin in the late 19th century, when the first evidence for the existence of viruses came from experiments using filters with pores small enough to retain bacteria. Dmitry Ivanovsky showed in 1892 that sap from a diseased tobacco plant remained infectious despite having been filtered; this agent, later known as tobacco mosaic virus, was the first virus to be demonstrated. In 1898, Friedrich Loeffler and Paul Frosch showed that foot-and-mouth, an animal disease, was caused by a filterable agent. That year, Martinus Beijerinck (pictured) called the filtered infectious substance a "virus" – often considered to mark the beginning of virology.

Bacteriophages, viruses that infect bacteria, were characterised by Frederick Twort and Félix d'Herelle in the early 20th century. In 1926, Thomas Milton Rivers defined viruses as obligate parasites. Viruses were demonstrated to be particles, rather than a fluid, by Wendell Meredith Stanley, and the invention of the electron microscope in 1931 allowed them to be visualised.

Selected outbreak

Passengers in Mexico City wearing face masks in an attempt to prevent infection
Passengers in Mexico City wearing face masks in an attempt to prevent infection

The 2009 flu pandemic was an influenza pandemic first recognised in Mexico City in March 2009 and declared over in August 2010. It involved a novel strain of H1N1 influenza virus with genes from five different viruses, which resulted when a previous triple reassortment of avian, swine and human influenza viruses further combined with a Eurasian swine influenza virus, leading to the term "swine flu" being used for the pandemic. It was the second pandemic to involve an H1N1 strain, the first being the 1918 "Spanish flu" pandemic.

The global infection rate was estimated as 11–21%. This pandemic strain was less lethal than previous ones, killing about 0.01–0.03% of those infected, compared with 2–3% for Spanish flu. Most experts agree that at least 284,500 people died, mainly in Africa and Southeast Asia – comparable with the normal seasonal influenza fatalities of 290,000–650,000 – leading to claims that the World Health Organization had exaggerated the danger.

Selected quotation

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

Electron micrograph of tobacco mosaic virus

Tobacco mosaic virus (TMV) is an RNA virus in the Virgaviridae family that infects a wide range of plants, including tobacco, tomato, pepper, other members of the Solanaceae family, and cucumber. The rod-shaped virus particle is around 300 nm long and 18 nm in diameter, and consists of a helical capsid made from 2130 copies of a single coat protein, which is wrapped around a positive-sense single-stranded RNA genome of around 6400 bases. The coat protein and RNA can self-assemble to produce infectious virus.

Infection often causes characteristic patterns, such as "mosaic"-like mottling and discoloration on the leaves, but is almost symptomless in some host species. TMV causes an economically important disease in tobacco plants. Transmission is frequently by human handling, and prevention of infection involves destroying infected plants, hand washing and crop rotation to avoid contaminated soil. TMV is one of the most stable viruses known. The fact that it does not infect animals and can readily be produced in gramme amounts has led to its use in numerous pioneering studies in virology and structural biology. TMV was the first virus to be discovered and the first to be crystallised.

Did you know?

Transgenic mouse and litter
Transgenic mouse and litter

Selected biography

George Keble Hirst (2 March 1909 – 22 January 1994) was an American virologist who was among the first to study the molecular biology and genetics of animal viruses.

Hirst started to work on influenza virus in 1940, only a few years after it had been isolated. He soon discovered that the virus caused red blood cells to clump together. This phenomenon could be used to diagnose influenza, which had previously required growing the virus in ferrets. He invented the haemagglutination assay, a simple method for quantifying viruses, and later the haemagglutination inhibition assay, which measures virus-specific antibodies in serum. In 1942, he discovered the neuraminadase enzyme, showing for the first time that viruses could contain enzymes. Neuraminidase is the target of the neuraminidase inhibitor class of antiviral drugs, including oseltamivir and zanamivir. In 1962, he was also the first to propose the then-revolutionary idea that virus genomes can consist of discontinuous segments.

He co-founded Virology in 1955, the first English-language journal to focus on viruses, and directed the Public Health Research Institute in New York City for nearly 25 years (1956–81).

In this month

Crystalline form of zidovudine, viewed in polarised light

March 1990: Proposal for a database of all viruses, later the ICTVdB

3 March 2014: Discovery of Pithovirus sibericum, the largest known virus at 1.5 μm long by 0.5 μm in diameter

4 March 1918: First case reported in the 1918 influenza pandemic

10 March 1956: Francis Crick and James Watson proposed that small viruses have a protein shell consisting of a large number of identical subunits

10 March 1956: Donald Caspar published paper on the structure of tomato bushy stunt virus

13 March 2003: Enfuvirtide (T20) approved; first HIV fusion inhibitor, also first HIV entry inhibitor

20 March 1987: Antiretroviral drug AZT (pictured) became the first antiviral medication approved for use against HIV/AIDS

22 March 2014: First case reported in the West African Ebola outbreak, the most widespread so far

26 March 1953: Jonas Salk reported a successful test of an inactivated polio vaccine.

28 March 2003: Mimivirus shown to be a virus, then the largest known

Selected intervention

Ball-and-stick model of nevirapine

Nevirapine (also Viramune) is an antiretroviral drug used in the treatment of HIV/AIDS caused by HIV-1. It was the first non-nucleoside reverse transcriptase inhibitor to be licensed, which occurred in 1996. Like nucleoside inhibitors, nevirapine inhibits HIV's reverse transcriptase enzyme, which copies the viral RNA into DNA and is essential for its replication. Unlike nucleoside inhibitors, it binds not in the enzyme's active site but in a nearby hydrophobic pocket, causing a conformational change in the enzyme that prevents it from functioning. Mutations in the pocket generate resistance to nevirapine, which develops rapidly unless viral replication is completely suppressed. The drug is therefore only used together with other anti-HIV drugs in combination therapy. The HIV-2 reverse transcriptase has a different pocket structure, rendering it inherently resistant to nevirapine and other first-generation NNRTIs. A single dose of nevirapine is a cost-effective way to reduce mother-to-child transmission of HIV, and has been recommended by the World Health Organization for use in resource-poor settings. Other protocols are recommended in the United States. Rash is the most common adverse event associated with the drug.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: